Guardant Health
GH
#1526
Rank
C$18.76 B
Marketcap
C$144.51
Share price
2.49%
Change (1 day)
180.85%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of September 2025 : C$1.83 Billion

According to Guardant Health 's latest financial reports the company's total debt is C$1.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$1.91 B6.77%
2023-12-31C$1.79 B-3.36%
2022-12-31C$1.85 B6.13%
2021-12-31C$1.75 B60.69%
2020-12-31C$1.08 B1965.09%
2019-12-31C$52.75 M
2018-12-31N/A-100%
2017-12-31C$0.82 M-96.38%
2016-12-31C$22.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Natera
NTRA
C$0.27 B-85.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
C$1.09 B-40.25%๐Ÿ‡บ๐Ÿ‡ธ USA